C-Path PRO Consortium measure used to support an FDA-approved label claim

(Critical Path Institute (C-Path)) C-Path Patient-Reported Outcome Consortium announces that clinical study results using the Consortium's Diary for Irritable Bowel Syndrome Symptoms-Constipation (DIBSS-C) were recently included in the expanded label for the drug LINZESS®.